RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2.


Journal

Microbial biotechnology
ISSN: 1751-7915
Titre abrégé: Microb Biotechnol
Pays: United States
ID NLM: 101316335

Informations de publication

Date de publication:
07 2020
Historique:
received: 27 03 2020
revised: 13 04 2020
accepted: 14 04 2020
pubmed: 26 4 2020
medline: 12 6 2020
entrez: 26 4 2020
Statut: ppublish

Résumé

The pandemic coronavirus SARS-CoV-2 in the world has caused a large infected population suffering from COVID-19. To curb the spreading of the virus, WHO urgently demanded an extension of screening and testing; thus, a rapid and simple diagnostic method is needed. We applied a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) to achieve the detection of SARS-CoV-2 in 30 min. We designed four sets of LAMP primers (6 primers in each set), targeting the viral RNA of SARS-CoV-2 in the regions of orf1ab, S gene and N gene. A colorimetric change was used to report the results, which enables the outcome of viral RNA amplification to be read by the naked eye without the need of expensive or dedicated instrument. The sensitivity can be 80 copies of viral RNA per ml in a sample. We validated the RT-LAMP method in a hospital in China, employing 16 clinic samples with 8 positives and 8 negatives. The testing results are consistent with the conventional RT-qPCR. In addition, we also show that one-step process without RNA extraction is feasible to achieve RNA amplification directly from a sample. This rapid, simple and sensitive RT-LAMP method paves a way for a large screening at public domain and hospitals, particularly regional hospitals and medical centres in rural areas.

Identifiants

pubmed: 32333644
doi: 10.1111/1751-7915.13586
pmc: PMC7264870
doi:

Substances chimiques

DNA Primers 0
Viral Proteins 0

Banques de données

GENBANK
['NC_045512.2']

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

950-961

Subventions

Organisme : Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford.
Pays : International

Informations de copyright

© 2020 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.

Références

J Clin Microbiol. 2005 Jan;43(1):427-30
pubmed: 15635005
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Chem Commun (Camb). 2017 Sep 26;53(77):10696-10699
pubmed: 28913529
Chem Commun (Camb). 2014 Apr 11;50(28):3747-9
pubmed: 24577617
Mol Cell Probes. 2002 Jun;16(3):223-9
pubmed: 12144774
Front Microbiol. 2015 Jan 12;5:770
pubmed: 25628612
Nat Med. 2015 Dec;21(12):1508-13
pubmed: 26552008
Biotechniques. 2015 Feb 01;58(2):59-68
pubmed: 25652028
J Clin Microbiol. 2002 Jul;40(7):2323-30
pubmed: 12089242
Nucleic Acids Res. 2002 Mar 15;30(6):1292-305
pubmed: 11884626
J Infect Chemother. 2009 Apr;15(2):62-9
pubmed: 19396514
Clin Microbiol Rev. 2006 Jan;19(1):165-256
pubmed: 16418529
Nucleic Acids Res. 2000 Jun 15;28(12):E63
pubmed: 10871386
Environ Microbiol. 2005 Sep;7(9):1339-48
pubmed: 16104857
Viruses. 2010 Aug;2(8):1804-20
pubmed: 21994708
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):4834-4842
pubmed: 30782834
J Clin Microbiol. 2007 Jun;45(6):1936-40
pubmed: 17392443
PLoS One. 2017 Feb 15;12(2):e0169011
pubmed: 28199317
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
Nat Protoc. 2008;3(5):877-82
pubmed: 18451795
J Clin Microbiol. 2004 May;42(5):1956-61
pubmed: 15131154

Auteurs

Wei E Huang (WE)

Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford, Suzhou Industrial Park, Jiangsu, China.
Department of Engineering Science, University of Oxford, Parks Road, OX1 3PJ, Oxford, UK.

Boon Lim (B)

Department of Engineering Science, University of Oxford, Parks Road, OX1 3PJ, Oxford, UK.

Chia-Chen Hsu (CC)

Department of Engineering Science, University of Oxford, Parks Road, OX1 3PJ, Oxford, UK.
Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK.

Dan Xiong (D)

Medical Laboratory of Shenzhen Luohu People's Hospital, Shenzhen, 518001, China.

Wei Wu (W)

Medical Laboratory of Shenzhen Luohu People's Hospital, Shenzhen, 518001, China.

Yejiong Yu (Y)

Department of Engineering Science, University of Oxford, Parks Road, OX1 3PJ, Oxford, UK.
Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK.

Huidong Jia (H)

Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford, Suzhou Industrial Park, Jiangsu, China.

Yun Wang (Y)

Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford, Suzhou Industrial Park, Jiangsu, China.

Yida Zeng (Y)

Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford, Suzhou Industrial Park, Jiangsu, China.

Mengmeng Ji (M)

Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford, Suzhou Industrial Park, Jiangsu, China.

Hong Chang (H)

Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford, Suzhou Industrial Park, Jiangsu, China.

Xiuming Zhang (X)

Medical Laboratory of Shenzhen Luohu People's Hospital, Shenzhen, 518001, China.

Hui Wang (H)

Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford, Suzhou Industrial Park, Jiangsu, China.

Zhanfeng Cui (Z)

Oxford Suzhou Centre for Advanced Research (OSCAR), University of Oxford, Suzhou Industrial Park, Jiangsu, China.
Department of Engineering Science, University of Oxford, Parks Road, OX1 3PJ, Oxford, UK.
Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH